2003
DOI: 10.1185/030079903125002559
|View full text |Cite
|
Sign up to set email alerts
|

Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation -an Italian perspective

Abstract: Short-term goals were achieved by the reforms, but long-term expectations were not. Drug de-reimbursement reduced both drug costs for the SSN and the number of GP consultations. Fewer patients were treated overall (mostly with advanced disease), with consequent disease worsening and increase in complications. An increase in CVI-related hospitalisation resulted. In contrast, preventative measures, including patient education and prophylactic treatment, exhibit both clinical and cost effectiveness. Larger studie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
1

Year Published

2007
2007
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 23 publications
0
7
0
1
Order By: Relevance
“…Nevertheless, even if all costs related to follow‐up in the surgery group are excluded from the analysis, surgery remains more costly. In Western countries, the treatment of varicose veins imposes a considerable burden on the healthcare budgets25, 26. In the Netherlands, €274 million a year is spent on the treatment of venous diseases, accounting for 6 per cent of total healthcare costs27.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, even if all costs related to follow‐up in the surgery group are excluded from the analysis, surgery remains more costly. In Western countries, the treatment of varicose veins imposes a considerable burden on the healthcare budgets25, 26. In the Netherlands, €274 million a year is spent on the treatment of venous diseases, accounting for 6 per cent of total healthcare costs27.…”
Section: Discussionmentioning
confidence: 99%
“…The use of standardized red vine leaf extract (AS 195), standardized horse chestnut extract, and oxerutin results in significant reduction of edema. In addition, red vine leaf extract and oxerutin have been shown to lead to significant improvement of symptoms , ].…”
Section: Therapymentioning
confidence: 99%
“…Because of the wide spectrum of factors that cause functional impairment in these patients and the high costs of treatment [2,3,8], the prevention of CVD by educational and prophylactic interventions has been shown to be clinically cost-effective, by avoiding disease progression to the last stages [49,54].…”
Section: Socioeconomic Impact Of Cvdmentioning
confidence: 99%